While tumours with wild-type TP53 showed a lack of YAP1 nuclear localisation in pancreatic cancer [58], a loss of p53 in mutant KRASG12D lung cancer leads to increased YAP1 nuclear localisation [63]. Here, TP53 is linked to lung cancer.